KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS
Revenue reached approximately RMB950.4 million, with total commercial sales RMB309.8million, representing a significant increase in proportionResearch and development expenses was approximately RMB611.5 millionLoss for the period was RMB145.2 million; adjusted...
Read more